| MolName | (5Z)-3-(oxolan-2-ylmethyl)-5-[(4-oxo-2-piperidin-1-ylpyrido[1,2-a]pyrimidin-3-yl)methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one |
| MolecularFormula | C22H24N4O3S2 |
| Smiles | O=C(/C(/S1)=C/C2=C(N3CCCCC3)N=C(C=CC=C3)N3C2=O)N(CC2OCCC2)C1=S |
| InChI | InChI=1S/C22H24N4O3S2/c27-20-16(13-17-21(28)26(22(30)31-17)14-15-7-6-12-29-15)19(24-9-3-1-4-10-24)23-18-8-2-5-11-25(18)20/h2,5,8,11,13,15H,1,3-4,6-7,9-10,12,14H2/t15-/m1/s1 |
| InChIK | QSLQJNQOONXVBD-OAHLLOKOSA-N |
| TotalMolweight | 456.59 |
| Molweight | 456.59 |
| MonoisotopicMass | 456.128981 |
| CLogP | 0.9641 |
| CLogS | -4.731 |
| H Acceptors | 7 |
| TotalSurfaceArea | 332.54 |
| Relative PSA | 0.31193 |
| PolarSurfaceArea | 122.84 |
| Druglikeness | 3.4462 |
| Mutagenic | none |
| Tumorigenic | none |
| Reproductive Effective | none |
| Irritant | none |
| Nasty Functions | polar activated DB |
| Shape Index | 0.45161 |
| Fragments | 1 |
| Non HAtoms | 31 |
| NonCHAtoms | 9 |
| Electronegative Atoms | 9 |
| StereoCenters | 1 |
| Rotatable Bond | 4 |
| Rings Closures | 5 |
| Small Rings | 5 |
| Sp3Atoms | 13 |
| Symmetricatoms | 2 |
| Amides | 2 |
| BasicNitrogens | 1 |
| StereoCon | racemate |
Click to Load Molecule:
1 - (5Z)-3-(oxolan-2-ylmethyl)-5-[(4-oxo-2-piperidin-1-ylpyrido[1,2-a]pyrimidin-3-yl)methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one | 2 - (5Z)-3-(oxolan-2-ylmethyl)-5-[(4-oxo-2-piperidin-1-ylpyrido[1,2-a]pyrimidin-3-yl)methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one